BrightSpring Health Services (BTSG) Set to Announce Quarterly Earnings on Thursday

BrightSpring Health Services (NASDAQ:BTSG) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.06 per share for the quarter. BrightSpring Health Services has set its FY 2024 guidance at EPS.Parties that are interested in registering for the company’s conference call can do so using this link.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings results on Thursday, February 29th. The company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.21). The firm had revenue of $2.38 billion for the quarter, compared to analyst estimates of $2.36 billion. The company’s quarterly revenue was up 20.5% on a year-over-year basis. On average, analysts expect BrightSpring Health Services to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

BrightSpring Health Services Stock Performance

BrightSpring Health Services stock opened at $10.78 on Thursday. The firm’s fifty day simple moving average is $9.88. The company has a current ratio of 1.17, a quick ratio of 0.84 and a debt-to-equity ratio of 5.73. BrightSpring Health Services has a 1-year low of $7.85 and a 1-year high of $12.14.

Insider Activity

In other BrightSpring Health Services news, CAO Jennifer A. Phipps bought 12,300 shares of the firm’s stock in a transaction dated Thursday, March 14th. The shares were acquired at an average cost of $8.14 per share, for a total transaction of $100,122.00. Following the transaction, the chief accounting officer now owns 165,618 shares in the company, valued at $1,348,130.52. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider James F. Mattingly, Jr. purchased 12,280 shares of BrightSpring Health Services stock in a transaction on Thursday, March 14th. The shares were purchased at an average cost of $8.18 per share, for a total transaction of $100,450.40. Following the completion of the transaction, the insider now directly owns 128,700 shares in the company, valued at $1,052,766. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Jennifer A. Phipps purchased 12,300 shares of BrightSpring Health Services stock in a transaction on Thursday, March 14th. The stock was purchased at an average price of $8.14 per share, for a total transaction of $100,122.00. Following the completion of the transaction, the chief accounting officer now owns 165,618 shares of the company’s stock, valued at $1,348,130.52. The disclosure for this purchase can be found here.

Analyst Upgrades and Downgrades

Several brokerages recently commented on BTSG. Wells Fargo & Company began coverage on shares of BrightSpring Health Services in a report on Tuesday, February 20th. They issued an “overweight” rating and a $15.00 target price on the stock. HSBC began coverage on shares of BrightSpring Health Services in a report on Wednesday, March 6th. They issued a “buy” rating and a $13.00 target price on the stock. UBS Group began coverage on shares of BrightSpring Health Services in a report on Tuesday, February 20th. They issued a “buy” rating and a $15.00 target price on the stock. Morgan Stanley began coverage on shares of BrightSpring Health Services in a report on Tuesday, February 20th. They issued an “overweight” rating and a $18.00 target price on the stock. Finally, Leerink Partnrs reiterated an “outperform” rating on shares of BrightSpring Health Services in a report on Tuesday, February 20th. Eleven analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $15.75.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.